Accès ouvert
2022
article
OpenAlex
Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul et autres
BACKGROUND AND OBJECTIVES: Masitinib is a selective tyrosine kinase inhibitor, targeting innate immune cells (mast cells and microglia) that are involved in the pathophysiology of progressive multiple sclerosis (MS). Study AB07002 assessed oral masitinib in patients with progressive MS who were progressing …
fr, es, pl, de
(code pays fourni par la source)
2017
article
OpenAlex
Magdalena Konopko, Halina Sienkiewicz‐Jarosz, Grzegorz Witkowski, M. Chahwan et autres
pl
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Grant Mair, Rüdiger von Kummer, Zoë Morris, Anders von Heijne et autres
OBJECTIVE: To investigate whether the location and extent of the CT hyperdense artery sign (HAS) at presentation affects response to IV alteplase in the randomized controlled Third International Stroke Trial (IST-3). METHODS: All prerandomization and follow-up (24-48 hours) CT brain scans in …
be, au, gb, se, it, de
(code pays fourni par la source)
Accès ouvert
2015
conference-abstract
OpenAlex
Magdalena Restel, Anna Bochyńska, M. Chahwan, Anna Grotkowska et autres
ISSN 2214-3599/15/$27.50 © 2015 – IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License. fi rst 3 years of treatment in two patients …
pl
(code pays fourni par la source)